MLchartDataset catalogue

AG3340

Term · Oncology and biomedicine · MLC-T-ONC-000318

A substance that is being studied in the treatment of cancer. It is a matrix metalloproteinase inhibitor and belongs to the family of drugs called angiogenesis inhibitors. Also called prinomastat.

Table 1. Record
IdentifierMLC-T-ONC-000318
FieldOncology and biomedicine
Expansionsprinomastat
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-000318",
  "term": "AG3340",
  "field": "Oncology and biomedicine",
  "definition": "A substance that is being studied in the treatment of cancer. It is a matrix metalloproteinase inhibitor and belongs to the family of drugs called angiogenesis inhibitors. Also called prinomastat.",
  "expansions": [
    "prinomastat"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/ag3340/"
}

Record 535 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.